Pancreatic Cancer Research

ResearcherRadboud University Medical CenterActive in the last 2 years

Pauline A. J. Vissers

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0677-888X; OpenAlex author ID A5039233448, A5069110599, A5111226752. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
49
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 3 papers · 2026: 4 papers

Papers 12

  1. The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analy… Co-author DOI 10.1016/j.ejca.2026.116822↗
  2. Gastrointestinal symptoms and health-related quality of life before and after pancreatectomy for pancreatic cancer (GO-PANC): longitudinal nationwide study. Co-author DOI 10.1093/bjs/znag122↗
  3. Continuity of care experienced by patients diagnosed with pancreatic cancer: nationwide multicentre study. Co-author DOI 10.1093/bjsopen/zrag033↗
  4. Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. Co-author DOI 10.1097/j.pain.0000000000004059↗
  5. Longitudinal health-related quality of life in patients with pancreatic cancer stratified by treatment: a nationwide cohort study. First author DOI 10.1016/j.eclinm.2024.103068↗
  6. Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOP… Co-author DOI 10.1093/bjs/znaf261↗
  7. Patient preferences for pancreatic cancer treatment (PERSEUS): a multicenter discrete choice experiment. Co-author DOI 10.1186/s12955-025-02440-5↗
  8. Impact of network treatment in patients with resected pancreatic cancer on use and timing of chemotherapy and survival. First author DOI 10.1093/bjsopen/zrad006↗
  9. Impact of multicentre diagnostic workup in patients with pancreatic cancer on repeated diagnostic investigations, time-to-diagnosis and time-to-treatment: A na… First author DOI 10.1016/j.ejso.2022.05.031↗
  10. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejca.2019.11.002↗
  11. Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population-based study. Co-author DOI 10.1002/cam4.1750↗
  12. Comparative performance of a modified landmark approach when no time of treatment data are available within oncological databases: exemplary cohort study among… Co-author DOI 10.2147/clep.s160973↗

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marc G. Besselink · 10 shared papers, 2018–2026 · strength 1.79
  2. Judith de Vos‐Geelen · 8 shared papers, 2020–2026 · strength 1.51
  3. Hanneke W.M. van Laarhoven · 7 shared papers, 2020–2026 · strength 1.38
  4. Lydia G. van der Geest · 8 shared papers, 2018–2026 · strength 1.21
  5. Martijn W.J. Stommel · 6 shared papers, 2022–2026 · strength 1.18
  6. Marjolein Y.V. Homs · 5 shared papers, 2025–2026 · strength 1.09
  7. Ignace H. J. T. de Hingh · 6 shared papers, 2020–2026 · strength 1.05
  8. Johanna W. Wilmink · 6 shared papers, 2018–2026 · strength 1.03
  9. Bert A. Bonsing · 4 shared papers, 2020–2026 · strength 0.73
  10. Vincent Erwin de Meijer · 4 shared papers, 2020–2026 · strength 0.73
  11. Hjalmar C. van Santvoort · 4 shared papers, 2020–2026 · strength 0.73
  12. Simone Augustinus · 3 shared papers, 2025–2026 · strength 0.67
  13. Lois A. Daamen · 3 shared papers, 2025–2026 · strength 0.62
  14. Jana S. Hopstaken · 3 shared papers, 2022–2026 · strength 0.56
  15. Lodewijk A.A. Brosens · 3 shared papers, 2022–2026 · strength 0.53
  16. Izaak Quintus Molenaar · 3 shared papers, 2020–2026 · strength 0.49
  17. Anne M. Gehrels · 2 shared papers, 2025–2026 · strength 0.45
  18. Cees J. H. M. van Laarhoven · 2 shared papers, 2023–2026 · strength 0.41
  19. Jeanin Elise van Hooft · 2 shared papers, 2026 · strength 0.41
  20. Casper H.J. van Eijck · 3 shared papers, 2018–2026 · strength 0.37
  21. Merlijn U.J.E. Graus · 1 shared paper, 2026 · strength 0.24
  22. Stefan A.W. Bouwense · 1 shared paper, 2026 · strength 0.24
  23. Nigel G. Kooreman · 1 shared paper, 2026 · strength 0.24
  24. Aniek E. van Diepen · 1 shared paper, 2026 · strength 0.24
  25. Sebastiaan Festen · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.